coronary stent

coronary stent

Intracoronary stent Cardiology An expandable tubular device which can be inserted percutaneously, and left within a coronary artery lumen to maintain its patency Pros Clinical and angiographic outcomes are better with intracoronary artery stent implantation than with standard balloon angioplasty, ↓ rate of restenosis and ↓ need for revascularization procedures Cons ↑ vascular complications, ↑ hospital stay. Radiation Cf Balloon angioplasty, Coronary artery bypass graft.
References in periodicals archive ?
Food and Drug Administration (FDA) has given its approval for Boston Scientific Corp.'s Ion paclitaxel-eluting platinum chromium coronary stent system and Taxus Liberte paclitaxel-eluting coronary stent for use in patients experiencing an acute myocardial infarction (AMI), or heart attack.
A unique combination of a one-time short and precise drug delivery with DEB during placement of a coronary stent is now for the first time approved and available in Europe.
Data collected by the Massachusetts Department of Public Health, which sponsored the study, on all patients who received a coronary stent in the state showed that use of drug-eluting stents (DES) was associated with a significantly lower risk of death or need for revascularization and a similar incidence of myocardial infarctions, compared with patients treated with bare-metal stents (BMS), Dr.
The paclitaxel-coated coronary stent program also entered human studies.
[USPRwire, Sun Nov 11 2018] Growing cases of coronary angioplasty (a treatment to widen narrowed sections of coronary arteries) is one of the key factors driving the demand for coronary stent grafts in hospitals, surgical centers and emergency rooms.
A coronary stent is a small cylindrical device used during percutaneous coronary intervention.
Navi Mumbai, India, March 07, 2015 --(PR.com)-- Market Reports on India presents the report on "Indian Coronary Stent Market Forecast to 2019" the Indian market and the market trends, potential future growth areas, and challenges for the sector.
Healthcare company Abbott Laboratories (NYSE:ABT) announced on Thursday the receipt of US Food and Drug Administration's (FDA's) approval for its XIENCE Xpedition Everolimus Eluting Coronary Stent System.
The ION Paclitax-eleluting platinum chromium coronary stent system is the company's third-generation drug-eluting stent technology.
Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, has announced at European Society of Cardiology in Stockholm that the results of follow-up tests undertaken ten years after the first patient was treated with a CYPHER(R) Sirolimus-eluting coronary stent have proven outstanding long-term efficacy and safety and were published earlier this year in "JACC: Cardiovascular Interventions".
The review included 5,342 patients at Prairie Heart who received their first drug-eluting coronary stent during May 2003--December 2006.